Clinical research in anaesthesia; randomized controlled trials or observational studies?
European Journal of AnaesthesiologyPublished 6 December 2006Open access
R.O. Feneck
Citations8
SJR quartileQ1
SJR score1.25
SNIP2.01
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The randomized controlled trial (RCT) remains the most highly regarded methodology in clinical research and indeed has been so for many decades, and many have bemoaned the lack of RCTs in assessing the efficacy of alternative medicine techniques.
Abstract
An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Keywords
Decision SciencesMedicine
Statistics in MedicinePropensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group
5,302 Citations1998Ralph B. D’Agostino
This tutorial discusses the uses of propensity score methods for bias reduction, gives references to the literature and illustrates the uses through applied examples.
Health Technology AssessmentEvaluating non-randomised intervention studies
2,926 Citations2003Jonathan J Deeks, Jacqueline Dinnes +6 more
The inability of case-mix adjustment methods to compensate for selection bias and the inability to identify non- randomised studies that are free of selection bias indicate that non-randomised studies should only be undertaken when RCTs are infeasible or unethical.
Annals of Internal MedicineEstimating Causal Effects from Large Data Sets Using Propensity Scores
2,879 Citations1997Donald B. Rubin
Propensity score methods generalize subclassification in the presence of many confounding covariates, such as age, region of the country, and sex, in a study of smoking and mortality.
New England Journal of MedicineThe Risk Associated with Aprotinin in Cardiac Surgery
1,109 Citations2006Dennis T. Mangano, Iulia Cristina Tudor +1 more
The association between aprotinin and serious end-organ damage indicates that continued use is not prudent, and the less expensive generic medications aminocaproic acid and tranexamic acid are safe alternatives.
New England Journal of MedicineComplications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac Surgery
1,094 Citations2005Nancy A. Nussmeier, Andrew Whelton +6 more
The use of parecoxib and valdecoxib after CABG was associated with an increased incidence of cardiovascular events, arousing serious concern about the use of these drugs in such circumstances.
Cochrane Database of Systematic ReviewsAnti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
1,068 Citations2011David Henry, Paul A Carless +5 more
Data from the head-to-head trials suggest an advantage of aprotinin over the lysine analogues TXA and EACA in terms of reducing perioperative blood loss, but the differences were small.
The LancetAllocation concealment in randomised trials: defending against deciphering
904 Citations2002Kenneth F. Schulz, David A. Grimes
Investigators must effectively immunise trials against selection and confounding biases with proper allocation concealment, andHypothesis tests of baseline characteristics, however, are superfluous and could be harmful if they lead investigators to suppress reporting any baseline imbalances.
BMJThe unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials
773 Citations1998Regina Kunz, Andrew D Oxman
On average, failure to use randomisation or adequate concealment of allocation resulted in larger estimates of effect due to a poorer prognosis in non-randomlyselected control groups compared with randomly selected control groups.
The LancetEFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERY
689 Citations1987David Royston, Kenneth M. Taylor +2 more
Of 22 patients undergoing repeat open-heart surgery through a previous median sternotomy wound 11 were randomised to receive the serine proteinase inhibitor aprotinin in high dosage, seven of whom received only the single unit of their own blood taken before cardiopulmonary bypass.
Journal of Thoracic and Cardiovascular SurgeryComparing apples and oranges
603 Citations2002Eugene H. Blackstone
For 3 decades, multivariable risk factor analysis has been the mainstay for identifying and quantifying treatment outcome differences adjusted for patient characteristics; however, Kirklin and Barratt-Boyes1 recommended that these differences be treated as associations with outcomes, not causes.
The LancetWhen are observational studies as credible as randomised trials?
526 Citations2004Jan P. Vandenbroucke
A proposal for a three-pronged restriction to give observational research the best chance to be as credible as randomised controlled trials is proposed.
BMJStatistics Notes: Blinding in clinical trials and other studies
483 Citations2000Simon Day
In controlled trials the term blinding, and in particular “double blind,” usually refers to keeping study participants, those involved with their management, and those collecting and analysing clinical data unaware of the assigned treatment, so that they should not be influenced by that knowledge.
Journal of Thoracic and Cardiovascular SurgeryEfficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery
403 Citations2003Elisabeth Ott, Nancy A. Nussmeier +8 more
In patients undergoing coronary artery bypass grafting surgery, the cyclooxygenase 2 inhibitor combination, parecoxib/valdecoxib, was effective for postoperative analgesia, however, the 14-day treatment regimen also was associated with an increased incidence of serious adverse events overall and sternal wound infections in particular.
TransfusionA propensity score case‐control comparison of aprotinin and tranexamic acid in high‐transfusion‐risk cardiac surgery
342 Citations2006Keyvan Karkouti, W. Scott Beattie +7 more
Prophylactic use of the antifibrinolytic drugs aprotinin and tranexamic acid is thought to prevent hemostatic defects in cardiopulmonary bypass patients.
Journal of Thoracic and Cardiovascular SurgeryEffect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: A systematic review and meta-analysis of randomized clinical trials
281 Citations2004Artyom Sedrakyan, Tom Treasure +1 more
Concerns that aprotinin therapy is associated with increased mortality, myocardial infarction, or renal failure risk is not supported by data from published, randomized, placebo-controlled clinical trials.
The LancetPutting clinical trials into context
188 Citations2005Charles Y.F. Young, Richard Horton
In recognition that journal editors have a key part to play in ensuring that published research is presented in a way that clearly illustrates why it was necessary and what impact a particular trial has on the existing state of knowledge, The Lancet has decided to update its policies in this area.
Clinical TrialsRandomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding?
164 Citations2005Dean Fergusson, Kathleen Cranley Glass +2 more
A cumulative meta-analysis indicated that aprotinin greatly decreased the need for perioperative transfusion, stabilizing at an odds ratio of 0.25 by the 12th study, published in June of 1992.
The Medical Journal of AustraliaPredictors of publication: characteristics of submitted manuscripts associated with acceptance at major biomedical journals
130 Citations2006Kirby P. Lee, Elizabeth A. Boyd +3 more
Objective: To identify characteristics of submitted manuscripts that are associated with acceptance for publication by major biomedical journals.
New England Journal of MedicineDangerous Deception — Hiding the Evidence of Adverse Drug Effects
61 Citations2006Jerry Avorn
Dr. Jerry Avorn writes that many aspects of the aprotinin saga are familiar to observers of the drug-evaluation process.
Pharmacotherapy The Journal of Human Pharmacology and Drug TherapyPharmacoepidemiology I: A Review of Pharmacoepidemiologic Study Designs
60 Citations2004Mahyar Etminan, Ali Samii
Four pharmacoepidemiologic study designs will be discussed that explore the association between a specific pharmacologic agent and a disease of interest: cohort studies, case‐control studies, cases‐crossover studies, and case‐time‐control Studies.
New England Journal of MedicineObservational Studies of Drug Safety — Aprotinin and the Absence of Transparency
52 Citations2006William R. Hiatt
Dr. William Hiatt writes that the recent discussions of aprotinin provide insight into the strengths and weaknesses of using observational data to assess drug safety and highlight the importance of using a transparent and open process when reviewing such data.
New England Journal of MedicineFirst, Gather the Data
47 Citations2006David G. Hunter
The relevance of ongoing surveillance to detect adverse events is explained and the body of evidence that is sufficient to demonstrate efficacy for a new drug is rarely large enough to provide absolute assurance that harmful side effects do not exist.
BMJWhy transition from alternation to randomisation in clinical trials was made
46 Citations1999Iain Chalmers
It is time to put the record straight about ways of controlling selection bias when generating comparison groups in clinical trials.
Anesthesia & AnalgesiaPediatric Research and Scholarship: Another Gordian Knot?
31 Citations2006Joseph R. Tobin, Steven L. Shafer +1 more
Four clinical papers on the use of dexmedetomidine in children are appearing in this issue of the journal, and the effect of this drug will be as salutary as the effects of opioids in the mortality of children having surgery for congenital heart disease is questioned.
The LancetThe risk of aprotinin: a conflict of evidence
30 Citations2006Artyom Sedrakyan, David Atkins +1 more
Journal of Cardiovascular ElectrophysiologyWhat is Right and What is Wrong About Evidence‐Based Medicine?
22 Citations2003Desmond G. Julian
Journal of Evaluation in Clinical PracticeEvidence‐based medicine and randomized double‐blind clinical trials: a study of flawed implementation
19 Citations2001M Kirk-Smith, David Stretch
It is recommended that to avoid this confound, methods of monitoring and accounting for experimenter beliefs and expectations should be routinely included in future RDBCTs.
Journal of Evaluation in Clinical PracticeSystematic reviews of randomized controlled trials: the need for complete data
15 Citations1995Michael J. Clarke, Lesley Stewart
Some of the reasons for this and some of the techniques used for individual patient data-based meta-analysis are set out, which will add to the analyses that can be performed and will remove many of the problems associated with a reliance on published data alone.
Journal of Cardiothoracic and Vascular AnesthesiaOPCAB surgery: time for a reappraisal?
3 Citations2004Robert Feneck